Verrica Pharmaceuticals Files 8-K on Financials
Ticker: VRCA · Form: 8-K · Filed: May 13, 2024 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Verrica Pharma dropped an 8-K on financials, check it for the latest numbers.
AI Summary
Verrica Pharmaceuticals Inc. filed an 8-K on May 13, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, but does not specify any new material events or transactions.
Why It Matters
This filing provides an update on Verrica Pharmaceuticals' financial status and operational results, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not appear to disclose any new material risks or events.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- May 13, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 46-3137900 (tax_id) — IRS Employer Identification No.
- West Chester, PA (location) — Principal Executive Offices
- (484) 453-3300 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Verrica Pharmaceuticals Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
On what date was this 8-K filing reported?
The earliest event reported in this 8-K filing was on May 13, 2024.
Where are Verrica Pharmaceuticals Inc.'s principal executive offices located?
Verrica Pharmaceuticals Inc.'s principal executive offices are located at 44 W. Gay St., Suite 400, West Chester, PA 19380.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (484) 453-3300.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-05-13 07:46:03
Filing Documents
- d805970d8k.htm (8-K) — 25KB
- d805970dex991.htm (EX-99.1) — 79KB
- g805970g0511094757162.jpg (GRAPHIC) — 3KB
- 0001193125-24-136715.txt ( ) — 240KB
- vrca-20240513.xsd (EX-101.SCH) — 3KB
- vrca-20240513_lab.xml (EX-101.LAB) — 18KB
- vrca-20240513_pre.xml (EX-101.PRE) — 11KB
- d805970d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release, dated May 13, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Verrica Pharmaceuticals Inc. Date: May 13, 2024 /s/ P. Terence Kohler Jr. P. Terence Kohler Jr. Chief Financial Officer